EYE:CSE, Rise Nano Optics Ltd.

EYE stock overview

Rise Nano Optics Ltd. (EYE:CSE) closed at $0.450 on October 23, 2026, unchanged on the day. The stock trades 64.0% below its 52-week high of $1.25 and 80.0% above its 52-week low of $0.250. Over the past year, it lost 40.0%. Rise Nano Optics Ltd. is part of the Technology sector.

Key figures

Price: $0.450
Day change: 0.00%
Volume: 500
Average volume: 3,072
Market cap: 18M+
52-week range: $0.250 – $1.25
50-day average: $0.358
200-day average: $0.501

Price action over the past year

In 155 trading sessions since March 13, 2026, EYE closed higher on 19 days (12%). Its best day was March 13, 2026 (+33.33%) and its worst was March 17, 2026 (-23.08%). The stock moved 10% or more in a single session 17 times. It opened at least 5% above the previous day's high 9 times.

Recent signals

Oct 23, 2026: Trading sideways between $0.450 and $0.500 over 14 days (Sideways scanner)
Oct 22, 2026: News catalyst: Private Placement (News Catalysts scanner)
Sep 1, 2026: Dropped 16.7% in a single session (Dips & Crashes scanner)

EYE news

Oct 22, 2026: Rise Nano Optics Announces Proposed Non-Brokered Private Placement of Up to C$5 Million
Oct 1, 2026: Rise Nano Optics to Attend the 2026 Cantech Investment Conference in Toronto
Sep 24, 2026: Rise Nano Optics to Sponsor INVISION MATCH! 2026, Connecting SpectraGuard with Leading Independent Eye Care Practices
Sep 16, 2026: Rise Nano Optics to Attend the Vision Council's 2026 Lab Leadership Forum
Aug 20, 2026: Rise Nano Optics Joins the Vision Council, a Leading Optical Trade Association, Expanding Access to Key Optical Relationship
Aug 10, 2026: Rise Nano Optics Announces Frankfurt Stock Exchange Listing
Aug 6, 2026: Rise Nano Optics Ltd. Announces AGSM Results
Aug 4, 2026: Rise Nano Optics Uplists to OTCQB Venture Market and Achieves DTC Eligibility, Expanding Access to U.S. Investors

About Rise Nano Optics Ltd.

Rise Nano Optics Ltd. is a health technology company specializing in advanced nanotechnology lens solutions designed to selectively filter high-energy visible light wavelengths. Its patented SPECTRAGUARD¿ technology integrates nanomaterial innovation, ophthalmic research and scalable optical engineering to serve both clinical and consumer eyewear markets globally.

Similar stocks

Find more stocks like EYE with the Spikes, Gaps, Breakouts and Performance Tracker scanners.

Based on end-of-day data. For information only, not investment advice.